title: Treatment of Priapism with Automated Red Cell Exchange and Hyperbaric Oxygen in an 11-year-old Patient with Sickle Cell Disease.
abstract: Priapism affects up to 50% of all males with sickle cell disease, and there is no standard treatment. Delayed and unsuccessful treatment leads to corporal fibrosis and impotence. It is therefore necessary to determine the best treatment methods for this complication in order to offer effective interventions to all affected patients. Herein we report an 11-year-old patient with sickle cell disease that presented with priapism 72 h after onset, and was successfully treated with automated red cell exchange and hyperbaric oxygen following unsuccessful surgical and conventional interventions.
authors.affiliation: Gülhane Military Medical Academy, Department of Pediatric Hematology, Ankara, Turkey.
authors.forename: Fatih Mehmet
authors.initials: FM
authors.lastname: Azık
authors.affiliation: Gülhane Military Medical Academy, Department of Pediatric Hematology, Ankara, Turkey.
authors.forename: Avni
authors.initials: A
authors.lastname: Atay
authors.affiliation: Gülhane Military Medical Academy, Department of Pediatric Hematology, Ankara, Turkey.
authors.forename: Ahmet Emin
authors.initials: AE
authors.lastname: Kürekçi
authors.affiliation: Gülhane Military Medical Academy, Department of Underwater and Hyperbaric Medicine, Ankara, Turkey.
authors.forename: Hakan
authors.initials: H
authors.lastname: Ay
authors.affiliation: Gülhane Military Medical Academy, Department of Urology, Ankara, Turkey.
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Kibar
authors.affiliation: Gülhane Military Medical Academy, Department of Pediatric Hematology, Ankara, Turkey.
authors.forename: Okan
authors.initials: O
authors.lastname: Ozcan
keywords: Automated red cell exchange; Hyperbaric oxygen therapy; Sickle cell disease; Treatment of priapism
references.citation: Am J Health Syst Pharm. 2004 Feb 15;61(4):355-63
references.pmid: 15011763
references.citation: J Urol. 1991 Jan;145(1):65-8
references.pmid: 1984102
references.citation: Mod Probl Ophthalmol. 1977;18:368-72
references.pmid: 876078
references.citation: BJU Int. 2002 Dec;90(9):898-902
references.pmid: 12460353
references.citation: Ther Apher. 2002 Feb;6(1):24-31
references.pmid: 11886573
references.citation: Br J Urol. 1989 Nov;64(5):541-5
references.pmid: 2692778
references.citation: Mod Probl Ophthalmol. 1975;15:313-7
references.pmid: 1160909
references.citation: Lancet. 1985 Dec 7;2(8467):1274-6
references.pmid: 2866338
references.citation: J Urol. 1987 Sep;138(3):592-4
references.pmid: 3625863
references.citation: Invest Ophthalmol Vis Sci. 1985 Aug;26(8):1155-8
references.pmid: 4019106
references.citation: JAMA. 1971 Jun 21;216(12):1977-8
references.pmid: 5108628
references.citation: Acad Emerg Med. 1996 Aug;3(8):810-6
references.pmid: 8853679
references.citation: J Urol. 1991 Jan;145(1):1-5
references.pmid: 1984062
references.citation: J Clin Anesth. 2001 Jun;13(4):255-8
references.pmid: 11435048
references.citation: Undersea Hyperb Med. 2002 Spring;29(1):1-3
references.pmid: 12507181
references.citation: Blood. 1991 Apr 1;77(7):1405-14
references.pmid: 2009364
references.citation: J Urol. 1996 Apr;155(4):1419-23
references.pmid: 8632602
references.citation: Arch Intern Med. 1980 Nov;140(11):1434-7
references.pmid: 6159833
references.citation: Ther Apher. 2000 Jun;4(3):256-8
references.pmid: 10910030
references.citation: J Urol. 1962 Jul;88:71-6
references.pmid: 13905169
references.citation: J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):518-22
references.pmid: 10598664
references.citation: J Crit Care. 2008 Sep;23(3):295-300
references.pmid: 18725032
references.citation: Hematol Oncol Clin North Am. 1996 Dec;10(6):1363-72
references.pmid: 8956023